Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.

Passalacqua S, Ferraro PM, Bresci G, D'Ovidio V, Astegiano M, Principi M, Testa R, D'Incà R, Valpiani D, Armuzzi A, Sablich R, Cavallaro F, Costa F, Di Leo V, Colombo E, Santini A, Aratari A, Lecis P, Saladino V, Riegler G, Marco M, Calella F, Ricci C, Guidi ML, Repaci G, Silla M.

J Clin Apher. 2011 Dec;26(6):332-7. doi: 10.1002/jca.20315. Epub 2011 Nov 9.

PMID:
22072543
[PubMed - indexed for MEDLINE]
2.

Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.

Martín de Carpi J, Vilar P, Prieto G, García Novo MD, Ribes C, Varea V.

J Pediatr Gastroenterol Nutr. 2008 Apr;46(4):386-91. doi: 10.1097/MPG.0b013e31815604e5.

PMID:
18367949
[PubMed - indexed for MEDLINE]
3.

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.

Lindberg A, Eberhardson M, Karlsson M, Karlén P.

BMC Gastroenterol. 2010 Jul 6;10:73. doi: 10.1186/1471-230X-10-73.

PMID:
20604939
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

Sands BE, Sandborn WJ, Wolf DC, Katz S, Safdi M, Schwartz DA, Hanauer SB.

J Clin Gastroenterol. 2006 Jul;40(6):482-9.

PMID:
16825929
[PubMed - indexed for MEDLINE]
5.

[Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease].

Registro Nazionale di Aferesi Terapeutica, Passalacqua S, Ferraro PM.

G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S61-3. Review. Italian.

PMID:
22388832
[PubMed - indexed for MEDLINE]
6.

Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.

Ljung T, Thomsen OØ, Vatn M, Karlén P, Karlsen LN, Tysk C, Nilsson SU, Kilander A, Gillberg R, Grip O, Lindgren S, Befrits R, Löfberg R.

Scand J Gastroenterol. 2007 Feb;42(2):221-7.

PMID:
17327942
[PubMed - indexed for MEDLINE]
7.

Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.

Sakata Y, Iwakiri R, Amemori S, Yamaguchi K, Fujise T, Otani H, Shimoda R, Tsunada S, Sakata H, Ikeda Y, Ando T, Nakafusa Y, Fujimoto K.

Eur J Gastroenterol Hepatol. 2008 Jul;20(7):629-33. doi: 10.1097/MEG.0b013e3282f5e9a4.

PMID:
18679064
[PubMed - indexed for MEDLINE]
8.

Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.

Ruuska T, Wewer V, Lindgren F, Malmborg P, Lindquist M, Marthinsen L, Browaldh L, Casswall T, Kalliomäki M, Grönlund J.

Inflamm Bowel Dis. 2009 Jul;15(7):1049-54. doi: 10.1002/ibd.20859.

PMID:
19137602
[PubMed - indexed for MEDLINE]
9.

Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.

Yoshino T, Nakase H, Matsuura M, Matsumura K, Honzawa Y, Fukuchi T, Watanabe K, Murano M, Tsujikawa T, Fukunaga K, Matsumoto T, Chiba T.

Digestion. 2011;84(1):3-9. doi: 10.1159/000321911. Epub 2011 Feb 9.

PMID:
21311190
[PubMed - indexed for MEDLINE]
10.

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.

Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I.

Clin Gastroenterol Hepatol. 2003 Jan;1(1):28-35.

PMID:
15017514
[PubMed - indexed for MEDLINE]
11.

A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.

Sands BE, Katz S, Wolf DC, Feagan BG, Wang T, Gustofson LM, Wong C, Vandervoort MK, Hanauer S.

Gut. 2013 Sep;62(9):1288-94. doi: 10.1136/gutjnl-2011-300995. Epub 2012 Jul 3.

PMID:
22760005
[PubMed - indexed for MEDLINE]
12.
13.

Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.

Yamamoto T, Umegae S, Matsumoto K.

J Gastroenterol. 2011 Aug;46(8):1003-9. doi: 10.1007/s00535-011-0428-4. Epub 2011 Jun 17.

PMID:
21681409
[PubMed - indexed for MEDLINE]
14.

Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.

Sacco R, Romano A, Mazzoni A, Bertini M, Federici G, Metrangolo S, Parisi G, Nencini C, Giampietro C, Bertoni M, Tumino E, Scatena F, Bresci G.

J Crohns Colitis. 2013 Dec 15;7(12):e692-7. doi: 10.1016/j.crohns.2013.06.012. Epub 2013 Jul 17.

PMID:
23870727
[PubMed - indexed for MEDLINE]
15.

In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.

Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, Numata Y, Kuga Y, Moriya T, Ohya T, Kajiyama G.

Dig Liver Dis. 2008 Sep;40(9):731-6. doi: 10.1016/j.dld.2008.02.012. Epub 2008 Apr 2.

PMID:
18387860
[PubMed - indexed for MEDLINE]
16.

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.

Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S; Adacolumn Study Group.

Gastroenterology. 2008 Aug;135(2):400-9. doi: 10.1053/j.gastro.2008.04.023. Epub 2008 Apr 25.

PMID:
18602921
[PubMed - indexed for MEDLINE]
17.

Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.

Andoh A, Tsujikawa T, Inatomi O, Deguchi Y, Hata K, Kitoh K, Sasaki M, Mitsuyama K, Fujiyama Y.

Ther Apher Dial. 2005 Apr;9(2):123-7.

PMID:
15828923
[PubMed - indexed for MEDLINE]
18.

Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

Muratov V, Lundahl J, Ulfgren AK, Elvin K, Fehrman I, Ahlborg N, Ost A, Hittel N, Saniabadi A, Löfberg R.

Int J Colorectal Dis. 2006 Sep;21(6):493-504. Epub 2006 Mar 15.

PMID:
16538495
[PubMed - indexed for MEDLINE]
19.

Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.

Sakimura K, Omori T, Iwashita E, Yoshida T, Tsuzuki Y, Fujimori K, Konishi F, Yoshida Y, Anzai H, Suzuki H, Sugawara S, Takeda Y, Hiraishi K, Saniabadi AR, Ide T, Miura S, Ota S.

Dig Dis Sci. 2006 Sep;51(9):1525-31. Epub 2006 Aug 12.

PMID:
16902810
[PubMed - indexed for MEDLINE]
20.

Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.

Sakuraba A, Sato T, Morohoshi Y, Matsuoka K, Okamoto S, Inoue N, Takaishi H, Ogata H, Iwao Y, Hibi T.

Ther Apher Dial. 2012 Jun;16(3):213-8. doi: 10.1111/j.1744-9987.2012.01064.x. Epub 2012 Apr 2.

PMID:
22607563
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk